COVID-19

Experts debunk 6 myths about the COVID-19 vaccine

Nurse immuniser Selena De Leon speaks with patient Karen Brooks after administering the AstraZeneca vaccine at a coronavirus disease (COVID-19) vaccination clinic at the Bankstown Sports Club as the city experiences an extended lockdown, in Sydney, Australia

There are many myths and misconceptions about the COVID-19 vaccine, which are currently affecting the vaccine uptake in some areas. Image: REUTERS/Loren Elliott

Neelaveni Padayachee
Lecturer, Department of Pharmacy and Pharmacology,, University of the Witwatersrand
Varsha Bangalee
Senior Lecturer, Pharmaceutical Sciences, University of KwaZulu-Natal
Share:
Our Impact
What's the World Economic Forum doing to accelerate action on COVID-19?
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

COVID-19

Loading...
  • Many people in South African are still hesitant to take the COVID-19 vaccine due to the spread of misinformation.
  • If not enough people accept their vaccine, it could become difficult to control the virus in this region.
  • Here, experts have addressed 6 popular misconceptions about COVID-19 vaccinations, explaining why they are incorrect.

South Africa’s COVID-19 vaccine rollout programme, outlined by the Ministry of Health, had three phases, starting with the most vulnerable population.

Phase one included all the frontline healthcare workers. They received the Johnson and Johnson vaccine. Phase 2 vaccinated people over 60 years old and those in congregate settings. The third and final phase, now under way, covers the remaining South African population.

The programme got off to a shaky start in February 2021. It encountered a number of setbacks such as supply, logistics and governance issues, but has gained momentum in recent weeks. As many as 200,000 doses are being administered daily. By the end of July 2021, almost 2.9% of the South African population had been fully vaccinated and 7.5% had their first of the two Pfizer doses.

Despite this uptake, many South Africans are still hesitant to take the vaccine. The circulation of misinformation about it poses the danger of hampering efforts to control the pandemic.

In this article, we aim to dispel some of the myths surrounding the COVID-19 vaccines.

Have you read?

Myth 1: The COVID-19 vaccine will affect a woman’s fertility

This myth was sparked when a social media post was shared in December 2020 by Dr Wolfgang Wodarg, a physician and former chief scientist for allergy and respiratory therapy at Pfizer, and Dr Michael Yeadon, a pulmonologist. They claimed that the spike protein on the coronavirus was the same as the spike protein that is responsible for the growth and attachment of the placenta during pregnancy. The fear was that, as a result of the vaccine, the immune system would not be able to differentiate between the two spike proteins and would attack the placental protein.

This is untrue. The overall makeup of the placental protein is very different from the coronavirus spike protein.

Additionally, during the Pfizer vaccine tests, 23 women volunteers became pregnant after taking the vaccine.

Furthermore, the benefits of being vaccinated outweigh the risks of infection for pregnant women.

Myth 2: I’ve had COVID-19, so I don’t need a vaccine

Reinfection with SARS-CoV-2, the virus that causes COVID-19, can occur even in individuals who have previously contracted the virus. But receiving the vaccine can provide protection against severe COVID-19 complications.

The level of protection that is achieved from natural immunity after being infected by the virus is unknown. But scientists believe that the vaccine provides better protection than natural infection.

Myth 3: COVID-19 vaccine side-effects are dangerous

Several studies have been conducted since the start of the pandemic that have measured South Africans’ perceptions of vaccine issues. A recent study by the University of Johannesburg and the Human Sciences Research Council of South Africa found that of the respondents who did not want to be vaccinated, 25% were concerned about side-effects.

Most of the side effects of the COVID-19 vaccine are mild. They include low grade fever, sore arm and fatigue, and these usually subside after one to three days.

Rare side effects such as blood clots have been reported from the Johnson and Johnson vaccine. The chances of experiencing this side effect are low. The risks of blood clots as a result of COVID-19 infection are 8-10 times higher than risks associated with the vaccine. Doctors are aware of this concern and are trained to identify and treat the condition quickly.

A recent article by Healthline – a medically reviewed and fact checked website – compared the benefits and risks of being vaccinated with those of contracting COVID-19. Lung damage is a complication of COVID-19 while muscle fatigue can be a side effect of the vaccine. This risk-benefit decision is left to the individual to make, but vaccinations have been proven to be safe.

Myth 4: Vaccines have a microchip that will track and control an individual

This conspiracy theory has been propagated by anti-vaxxers who believe that the American business magnate, investor and philanthropist Bill Gates will implant microchips to track people’s movement, using the vaccine as the method of delivery. This is untrue and has been clarified by Gates in the media.

This myth gained traction when a video was shared on Facebook making false claims about the optional microchip on the syringe’s label of the COVID-19 vaccine. This microchip’s purpose is to confirm that the injectable and the vaccine are not counterfeit and haven’t expired. It will also confirm if the injection has been used.

People commenting on the video appeared to have misinterpreted the technology as an injectable. But the microchip is part of the syringe label and not the injectable substance itself.

Myth 5: The COVID-19 vaccine development was rushed, so it may not be effective

The vaccine was developed very quickly. This was possible because the vaccine technology had been in development for many years. When the genetic information of SARS-CoV-2 was identified, the process could begin quickly. There were sufficient resources to fund the research and social media made it easier to recruit participants for the clinical trials. Because SARS-CoV-2 is contagious, it was easy to tell whether the vaccine worked or not.

Discover

What is the World Economic Forum doing about access to vaccines?

Myth 6: The COVID-19 vaccine can alter my DNA

The messenger RNA vaccine (Pfizer) and the viral vector vaccine (Johnson and Johnson) cause your body to develop protection, so that when you are infected by SARS-CoV-2, your body is prepared to fight the virus. DNA is located in the nucleus of your cells and the vaccine material does not enter the nucleus. So it does not alter the DNA.

Loading...
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
COVID-19Health and Healthcare
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Winding down COVAX – lessons learnt from delivering 2 billion COVID-19 vaccinations to lower-income countries

Charlotte Edmond

January 8, 2024

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum